Effects of palmitate on Ca2+ handling in adult control and ob/ob cardiomyocytes: Impact of mitochondrial reactive oxygen species

Diabetes

Volumn 56, Issue 4, 2007, Pages 1136-1142

  Fauconnier, Jérémy ^a   Andersson, Daniel C ^a   Zhang, Shi Jin ^a   Lanner, Johanna T ^a   Wibom, Rolf ^a   Katz, Abram ^a   Bruton, Joseph D ^a   Westerblad, Håkan ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; CALCIUM ION; EBSELEN; FATTY ACID; INSULIN; PALMITIC ACID; REACTIVE OXYGEN METABOLITE; TETRAMETHYLRHODAMINE ETHYL ESTER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CALCIUM TRANSPORT; CELL STIMULATION; CELL STRUCTURE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOSOL; DIABETES MELLITUS; ELECTROSTIMULATION; FATTY ACID METABOLISM; HEART CONTRACTION; HEART MUSCLE CELL; IN VIVO STUDY; INSULIN RESISTANCE; MALE; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL RESPIRATION; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; SARCOPLASMIC RETICULUM;

ANIMALS; CALCIUM; HEART; HEART VENTRICLES; LEPTIN; MEMBRANE POTENTIALS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MITOCHONDRIA, HEART; MUSCLE CELLS; PALMITIC ACID; REACTIVE OXYGEN SPECIES;

EID: 34047176377     PISSN: 00121797     EISSN: 00121797     Source Type: Journal    
DOI: 10.2337/db06-0739     Document Type: Article

References (45)

1. Stanley WC, Recchia FA, Lopaschuk GD: Myocardial substrate metabolism in the normal and failing heart. Physiol Rev 85:1093-1129, 2005
2. Carley AN, Severson DL: Fatty acid metabolism is enhanced in type 2 diabetic hearts. Biochim Biophys Acta 1734:112-126, 2005
3. Mazumder PK, O'Neill BT, Roberts MW, Buchanan J, Yun UJ, Cooksey RC, Boudina S, Abel ED: Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob/ob mouse hearts. Diabetes 53:2366 -2374, 2004
4. Boudina S, Sena S, O'Neill BT, Tathireddy P, Young ME, Abel ED: Reduced mitochondrial oxidative capacity and increased mitochondrial uncoupling impair myocardial energetics in obesity. Circulation 112:2686 -2695, 2005
5. Levy J: Abnormal cell calcium homeostasis in type 2 diabetes mellitus: a new look on old disease. Endocrine 10:1- 6, 1999
6. Fang ZY, Prins JB, Marwick TH: Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr Rev 25:543-567, 2004
7. Belke DD, Swanson EA, Dillmann WH: Decreased sarcoplasmic reticulum activity and contractility in diabetic db/db mouse heart. Diabetes 53:3201-3208, 2004
8. Flarsheim CE, Grupp IL, Matlib MA: Mitochondrial dysfunction accompanies diastolic dysfunction in diabetic rat heart. Am J Physiol 271:H192-H202, 1996
9. Duchen MR: Roles of mitochondria in health and disease. Diabetes 53 (Suppl. 1):S96 -S102, 2004
10. Brownlee M: The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54:1615-1625, 2005
11. Kourie JI: Interaction of reactive oxygen species with ion transport mechanisms. Am J Physiol 275:C1-C24, 1998
12. Giordano FJ: Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest 115:500 -508, 2005
13. Zima AV, Blatter LA: Redox regulation of cardiac calcium channels and transporters. Cardiovasc Res 71:310 -321, 2006
14. 2+ handling defects in cardiomyocytes of ob/ob mice. Diabetes 54:2375-2381, 2005
15. Sambrano GR, Fraser I, Han H, Ni Y, O'Connell T, Yan Z, Stull JT: Navigating the signalling network in mouse cardiac myocytes. Nature 420:712-714, 2002
16. Duchen MR, Leyssens A, Crompton M: Transient mitochondrial depolarizations reflect focal sarcoplasmic reticular calcium release in single rat cardiomyocytes. J Cell Biol 142:975-988, 1998
17. Ooe H, Taira T, Iguchi-Ariga SM, Ariga H: Induction of reactive oxygen species by bisphenol A and abrogation of bisphenol A-induced cell injury by DJ-1. Toxicol Sci 88:114 -126, 2005
18. Gardner PR: Aconitase: sensitive target and measure of superoxide. Methods Enzymol 349:9 -23, 2002
19. Srere PA: Citrate synthase: [EC 4.1.3.7. Citrate oxaloacetate-lyase (CoA-acetylating)]. Methods Enzymol 13:3-11, 1969
20. 2+ release. Circ Res 92:904 -911, 2003
21. Cotgreave IA, Sandy MS, Berggren M, Moldeus PW, Smith MT: N-acetylcysteine and glutathione-dependent protective effect of PZ51 (Ebselen) against diquat-induced cytotoxicity in isolated hepatocytes. Biochem Pharmacol 36:2899 -2904, 1987
22. Storz P, Döppler H, Toker A: Protein kinase D mediates mitochondrionto-nucleus signaling and detoxification from mitochondrial reactive oxygen species. Mol Cell Biol 25:8520-8530, 2005
23. O'Rourke B, Ramza BM, Marban E: Oscillations of membrane current and excitability driven by metabolic oscillations in heart cells. Science 265: 962-966, 1994
24. 2+ waves in cat atrial myocytes. J Physiol 545:65-79, 2002
25. Eisner DA, Diaz ME, Li Y, O'Neill SC, Trafford AW: Stability and instability of regulation of intracellular calcium. Exp Physiol 90:3-12, 2005
26. Unger RH, Orci L: Diseases of liporegulation: new perspective on obesity and related disorders. FASEB J 15:312-321, 2001
27. Listenberger LL, Schaffer JE: Mechanisms of lipoapoptosis: implications for human heart disease. Trends Cardiovasc Med 12:134 -138, 2002
28. Ye G, Metreveli NS, Donthi RV, Xia S, Xu M, Carlson EC, Epstein PN: Catalase protects cardiomyocyte function in models of type 1 and type 2 diabetes. Diabetes 53:1336 -1343, 2004
29. Sparagna GC, Hickson-Bick DL, Buja LM, McMillin JB: A metabolic role for mitochondria in palmitate-induced cardiac myocyte apoptosis. Am J Physiol Heart Circ Physiol 279:H2124-H2132, 2000
30. Listenberger LL, Ory DS, Schaffer JE: Palmitate-induced apoptosis can occur through a ceramide-independent pathway. J Biol Chem 276:14890-14895, 2001
31. Miller TA, LeBrasseur NK, Cote GM, Trucillo MP, Pimentel DR, Ido Y, Ruderman NB, Sawyer DB: Oleate prevents palmitate-induced cytotoxic stress in cardiac myocytes. Biochem Biophys Res Commun 336:309 -315, 2005
32. Loskovich MV, Grivennikova VG, Cecchini G, Vinogradov AD: Inhibitory effect of palmitate on the mitochondrial NADH: ubiquinone oxidoreductase (complex I) as related to the active-de-active enzyme transition. Biochem J 387:677- 683, 2005
33. 2+ channel. Mol Pharmacol 53:497-503, 1998
34. Goldhaber JI, Qayyum MS: Oxygen free radicals and excitation-contraction coupling. Antioxid Redox Signal 2:55- 64, 2000
35. 2+ -ATPase of cardiac sarcoplasmic reticulum. Mol Cell Biochem 248:41- 47, 2003
36. Buchanan J, Mazumder PK, Hu P, Chakrabarti G, Roberts MW, Yun UJ, Cooksey RC, Litwin SE, Abel ED: Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity. Endocrinology 146:5341-5349, 2005
37. How OJ, Aasum E, Severson DL, Chan WY, Essop MF, Larsen TS: Increased myocardial oxygen consumption reduces cardiac efficiency in diabetic mice. Diabetes 55:466-473, 2006
38. Coort SL, Luiken JJ, van der Vusse GJ, Bonen A, Glatz JF: Increased FAT (fatty acid translocase)/CD36-mediated long-chain fatty acid uptake in cardiac myocytes from obese Zucker rats. Biochem Soc Trans 32:83- 85, 2004
39. 2+ release in rats via mitochondriadependent and -independent mechanisms. J Physiol 550:765-783, 2003
40. Carvajal K, Banos G, Moreno-Sanchez R: Impairment of glucose metabolism and energy transfer in the rat heart. Mol Cell Biochem 249:157-165, 2003
41. Xiang JZ, Kentish JC: Effects of inorganic phosphate and ADP on calcium handling by the sarcoplasmic reticulum in rat skinned cardiac muscles. Cardiovasc Res 29:391- 400, 1995
42. 2+ release by glycolysis in cat atrial myocytes. J Physiol 564:697-714, 2005
43. 2+ transport. Circ Res 77:88 -97, 1995
44. Hüser J, Wang YG, Sheehan KA, Cifuentes F, Lipsius SL, Blatter LA: Functional coupling between glycolysis and excitation-contraction coupling underlies alternans in cat heart cells. J Physiol 524:795- 806, 2000
45. Diaz ME, O'Neill SC, Eisner DA: Sarcoplasmic reticulum calcium content fluctuation is the key to cardiac alternans. Circ Res 94:650-656, 2004